CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
Critical milestone achieved—the FDA accepted CEL-SCI’s selection criteria defining the Multikine target population before surgery Selected patient population... Read more.
Manhattan Prep/Kaplan Survey: Most Future Business School Applicants Wary About Unrestricted Use of AI in Admissions Essays
FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#gmat–A new Manhattan Prep/Kaplan survey of more than 300 aspiring MBA students finds mixed attitudes toward... Read more.
Arcserve Earns Premier 5-Star Rating in 2024 CRN Partner Program Guide
Data Resilience Provider Recognized for Enhancing Partner Profitability, Driving Mutual Growth and Success EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–#backup—Arcserve®,... Read more.
LSAK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Lesaka Technologies, Inc. Is Fair to Shareholders
NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Lesaka Technologies, Inc. (NASDAQ: LSAK)... Read more.
Global Cystatin C Assay Industry Research 2024-2033: Technological Innovations and Regulatory Frameworks Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Cystatin C Assay Market: Focus on Applications, End Users, Types, Methods, Sample and Over 14 Countries’... Read more.
PROS Announces Investor Conference Schedule for May 2024
HOUSTON–(BUSINESS WIRE)–PROS Holdings, Inc. (NYSE: PRO), a leading provider of AI-powered SaaS pricing, CPQ, revenue management, and digital offer marketing... Read more.
Fernando Rivas to Join Wells Fargo as Co-CEO of Corporate & Investment Banking
SAN FRANCISCO–(BUSINESS WIRE)–Wells Fargo & Company (NYSE: WFC) announced today that Fernando Rivas has been named SEVP and Co-CEO of Corporate &... Read more.
5G Substrate Materials Market – Global and Regional Analysis and Forecast, 2024-2034 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “5G Substrate Materials Market – Global and Regional Analysis: Focus on Product, Application and Country-Wise... Read more.
Bayer to unveil late-breaking data from Phase III OASIS 1 and 2 for elinzanetant in the treatment of vasomotor symptoms associated with menopause
Detailed results from pivotal Phase III studies OASIS 1 and 2 evaluating the efficacy and safety of investigational compound elinzanetant will be presented for the... Read more.
Web3 Gaming Powerhouse Emerges: MixMarvel and Yeeha Forge Galaxy Girl Interactive
SINGAPORE–(BUSINESS WIRE)–#AI–Web3 content leader MixMarvel and gaming giant Yeeha Games announced a groundbreaking partnership at Token2049 Dubai,... Read more.